Latest News
Pharmapack Europe 2026
SAXOCON will be at Pharmapack Europe 2026, stand S25, on 21 & 22 January. Stop by our stand and find out how we can help you ensure your packaging is safe and compliant. Containers and other primary packaging systems for drug products must be designed, tested, and documented as not affecting the safety or quality of the finished product. Both...
ISO 10993-1 Updated
ISO 10993-1 is the foundational standard for the biological evaluation of medical devices within a risk management process. It specifies the general principles for assessing the biological safety of medical devices that come into contact with the body. The latest revision, ISO 10993-1:2025, significantly strengthens the risk-based approach and...
New ISO 10993-1 Edition in Final Draft International Standard (FDIS) Stage
We are pleased to share that a new edition of ISO 10993-1, the cornerstone standard for the biological evaluation of medical devices, has reached the Final Draft International Standard (FDIS) stage. This means the updated version — ISO/FDIS 10993-1:2025 — is now out for a final vote among ISO member bodies. The new edition includes significant...
Technically Unavoidable Particles
Technically Unavoidable Particles (TUPs) are always present in excipients. Concern regarding their presence has increased dramatically in recent years due to several US FDA warning letters to pharmaceutical companies, highlighting adverse findings during inspections. SAXOCON can help pharmaceutical manufacturers develop their Technically...
SAXOCON at ISO TC 194
From October 21–25, SAXOCON's Chief Technical Officer, Carsten Baun Senholt, will participate in the ISO Technical Committee 194 (ISO TC 194) plenary meeting in Paris. Carsten is one of the many experts contributing to the scientific and technical collaboration needed to develop coherent, scientifically valid, and effective worldwide medical...
Particle Count Testing
SAXOCON provides microscopic particle count testing in accordance with Method 2 in USP-NF (788). Testing is conducted in our Class N2 clean workspace according to our internal protocols to guarantee the precise identification and measurement of particles that satisfy ISO standards and are essential for preserving product safety. Our service...
Ensure Product Safety through Rigorous Particulate Contamination Testing
Pharmaceutical and medical device manufacturers need to ensure the safety of the materials used in their products. Particulate contamination is a risk in production facilities. Good Manufacturing Practice (GMP) and proper risk management require the identification of root causes and evaluating the impact that particulate matter findings can have...
New Regulations for Silicone
Last fall, the European Chemicals Agency (ECHA) won a decisive judgement at the European Court of Justice. This judgement allows the ECHA to classify silicone oligomers, specifically D4, D5, and D6 siloxanes, as Persistent Bioaccumulative and Toxic substances (PBT), Very Persistent and Very Bioaccumulative substances (vPvB), and as suspected to...
CE Certification of Implants
Medical device manufacturers must ensure the biosafety of their medical implant products to comply with relevant regulations. Medical implants have intimate contact with the human body for durations lasting a few hours to permanently. As such, they are subject to strict regulations regarding their safety. To sell an implant in the EU, it must...
ISO 13485, GMP, MDR, and Supply Chain Confidence
Whether you are a pharmaceutical or medical device manufacturer, you need to comply with several layers of guidelines and regulations to bring your products to market and keep them there. Having suppliers you can trust is crucial to your ability to concentrate on making your products the best they can be. SAXOCON is ISO 13485 certified, allowing...
Starting Up Right
Being part of a startup can be an exhilarating experience; working together to create new and exciting products, combining the talents and vision of your co-workers, and riding on the wave of enthusiasm make the blood, sweat, and tears worth it. But just when you think you are ready to go to market, you fall at the final hurdle: approval denied...
Unexpected Findings in Production
Pharmaceutical and medical device manufacturers and materials suppliers must ensure their products are not shedding harmful particles. Unexpected particulate findings during production are a risk that all manufacturers face. Sudden, unexpected findings of particulate matter in or in contact with products can occur in production facilities. Good...
Contamination in Pharmaceutical Production
One of the key responsibilities of pharmaceutical manufacturers is to test the materials used in the manufacturing process to ensure safety and compliance and keep production running smoothly. At SAXOCON, we have the in-house expertise and experience to help you quickly assess and test your production components and materials. One of the greatest...
BPOG, USP 665 and 1665 and You
In May this year, US Pharmacopeia (USP) chapter 665 will come into effect, and mandatory testing for extractables and leachables (E&L) studies of plastic single-use systems are now required. Moreover, the BioPhorum Operations Group (BPOG) industry collaboration has published protocols that provide comprehensive data, which allows...
FDA Recognizes ISO 10993:17
The FDA has just recognized the recently updated ISO 10993 Part 17 standard covering the toxicological risk assessment of medical device constituents. Apart from a few exceptions, the FDA recognized the standard for its relevance and scientific and technical merit. ISO 10993-17:2023 introduces some new concepts for toxicological risk assessments,...
Major Change: EU Can Classify Silicone as a Restricted Substance
Do you use silicone in the medical devices you produce? If so, you need to be aware that the European Chemicals Agency (ECHA) can now classify silicone oligomers, specifically D4, D5, and D6 siloxanes, as Persistent Bioaccumulative and Toxic substances (PBT), Very Persistent and Very Bioaccumulative substances (vPvB), and suspected to be toxic to...
Materials Screening
Medical device manufacturers need to screen the materials used in their products. Proper biosafety and sourcing require having full transparency about the physical and chemical information associated with the materials throughout the supply chain. Knowing what is in the materials you use helps mitigate risk, reduces unexpected findings, and keeps...
Nitrosamine Impurities in Primary Packaging
Pharmaceutical manufacturers need to know whether their products contain nitrosamine impurities and, if so, whether they are below the thresholds established by various regulatory agencies. Nitrosamines are highly toxic compounds, with some considered even more carcinogenic than currently established thresholds suggest and are, therefore, subject...
Updated ISO 10993-17:2023 Standard
The ISO 10993 standard series covers the biological evaluation of medical devices. Part 17 of this series addresses the toxicological risk of chemical constituents resulting from the chemical characterization of medical devices. In its first major revision in 20 years, the new ISO 10993-17:2023 was published on 13 September. This update has...
New FDA NDSRI Guidelines
The Food and Drug Administration (FDA) is updating its guidance regarding Nitrosamine Drug Substance-Related Impurities (NDSRIs). With this update, the FDA acknowledges the leading scientific research by introducing a novel framework for determining the Acceptable Intake (AI) of NDSRIs. This updated guidance defines five NDSRI potency categories...
New ECHA Chemicals Enforcement Project
Get ready for the enhanced enforcement mechanisms for products sold online in the EU. Make sure your products are compliant with REACH and CLP requirements.
Particulate Contamination
Particulate contamination is a risk in pharmaceutical production facilities. Good Manufacturing Practice (GMP) and proper risk management requires identifying root causes and evaluating what impact a particulate matter finding has on product safety. Understanding the risk as quickly as possible is crucial when deciding whether to release or...
Nitrosamine Contamination
As a pharmaceutical manufacturer, you need to know whether your products contain nitrosamine impurities and, if so, whether they are below the thresholds established by various regulatory agencies. Nitrosamine impurities can be introduced at any stage in the supply chain, during manufacturing, or as leachables from packaging and storage....
ISO 10993-17 Development
We are very proud that our CTO, Carsten Senholt, has a central role in the international writing group developing ISO 10993-17, which was recently submitted as a final draft. The ISO 10993 series is a suite of standards covering the biological evaluation of medical devices. The newly revised part 17 now covers the toxicological risk assessment of...
ISO 13485 and MDR
According to EU Regulation (EC) 2017/745 (MDR) and US 21 CFR 820 covering medical devices, manufacturers must demonstrate that their selected critical suppliers, contractors, and consultants meet all specified requirements, including quality requirements. These regulations hold manufacturers fully responsible for all outsourced processes....
In Silico and the FDA
The FDA Modernization Act to end animal testing has passed the US Senate. This change nullifies the old mandate requiring animal testing of all new drugs, thereby increasing the acceptance and use of Quantitative Structure-Activity Relationship (QSAR) and read-across (RAX) methods for toxicity testing. In-silico methods reduce the need for animal...
Nitrosamines
Are you a pharmaceutical manufacturer? Do you know whether your products contain nitrosamine impurities and, if so, whether they are below the thresholds established by the various regulatory agencies? SAXOCON has the expertise and services necessary to help you to fill in the gaps in your supply chain information and assess the impact on your...
MDR and Biological Safety
Complying with EU Medical Device Regulation (MDR) is not optional. If you are a manufacturer, authorised representative or distributor of medical devices, you will need to ensure compliance with EU MDR. Non-compliance with biological safety requirements can result in costly delays when designing, developing or selling a medical device. SAXOCON...
Congrats to the 2022 Danish Tech Challenge Participants
As a member of the DTU family, we would like to congratulate the 19 participants in the 2022 Danish Tech Challenge, Denmark's leading accelerator for hardware start-ups, at the DTU Science Park Futurebox incubator. At SAXOCON, we specialise in in-silico toxicological testing, risk assessment, and regulatory documentation for pharmaceutical...
On-site Aerosol Sampling
Exposure to aerosols can negatively affect health. Using our SAXOCON Impactor tool, we can determine what is in the air at your workplace, if there are any risks, and how to mitigate potential problems. We designed and built the SAXOCON Impactor to be a highly efficient, multi-stage impactor that collects airborne particles (down to the...
GAeF Membership
Our CSO, Kirsten Inga Kling, has joined GAeF (Gesellschaft für Aerosolforschung e.V.) as a supporting member. We look forward to contributing to the discussion, learning, and sharing knowledge with other experts in aerosol research. Check out our analytics services here.
Celebrating Arla’s BLG Novel Food Application Success
SAXOCON congratulates Arla Foods Ingredients on the positive EFSA opinion regarding their novel food application for Lacroprodan® BLG-100. We are proud that our contribution helped get the application over the finish line and look forward to Arla receiving full EU approval for BLG later this year. Read more about Arla Foods Ingredients'...
FDA CGMP Requirements Incorporating ISO 13485
We are on the verge to merge. Things in the regulatory space for medical device manufacturers are about to get easier. In a new proposal on Quality System Regulation Amendments for Medical Devices, The FDA has decided to harmonize their GMP requirement for medical devices by incorporating the QMS requirements from ISO 13485. This harmonization...
Food Contact Materials Biosafety
Packaging is not the first thing we think of when we think of food. However, the biosafety of the materials used in food packaging impact the food contained within. So, it is essential to understand the health and safety consequences of the packaging. For more information, read this EFSA article on food contact materials regulations. All food...
Biosafety and In-Vitro Diagnostics
A CE certificate verifies the biosafety of your products and that they perform as intended.
Material Readiness and Marketability
To know your materials is the beginning of wisdom.
Medical Implant Biosafety
Ensuring the biosafety of your medical implants is necessary for getting them in compliance with relevant regulations. Medical implants come into intimate contact with the human body for periods lasting from a few hours to permanently. As such, they are subject to strict regulations regarding their safety. Manufacturers of medical implants need...
Workplace Air Quality
Are you a manufacturer? Do you know what particles your workers are exposed to in your working environment? Whether it's additive manufacturing, assembly, welding or any other process that produces dust or fumes, your workers are being exposed to particles. Mitigating any health concerns for your workers requires understanding how many and the...
Reusable Medical Device Safety
Do you manufacture reusable medical devices? If so, your products are likely used in medical facilities around the world. In the EU, manufacturers wanting to sell reusable medical devices must ensure that their cleaning, disinfection, and sterilisation procedures are validated. SAXOCON has the expertise to help you get your procedures into...
EFSA Deadline for Food Enzyme Documentation Fast Approaching
EFSA has set the deadline for submitting updated documentation regarding food enzymes for April 2022. Are you ready? We are.
Chemically Non-compliant Products Sold Online in EU
A recent report by the ECHA found that over half the products sold online in the EU were non-compliant with one or more EU requirements with regard to chemicals. These findings resulted in more than 5000 enforcement actions by national authorities. As a product manufacturer, this is an entirely avoidable problem. With the proper understanding and...
Nitrosamine Impurities
Are you a pharmaceutical manufacturer? Do you know whether your products contain nitrosamine impurities and, if so, whether they are below the thresholds established by the various regulatory agencies? SAXOCON has the expertise and services necessary to help you to fill in the gaps in your supply chain information and assess the impact on your...
SAXOCON at the COMPAMED/MEDICA Trade Fair 2021
SAXOCON is participating at the COMPAMED/MEDICA trade fair in Düsseldorf, we will be there on November 15-17. We will have a booth at the Danish Pavilion. Come and meet us there. Click here for more information.
Reduce Animal Testing
Every day people are exposed to chemicals from a variety of sources such as food products, cosmetics, clothing, medical devices, and medicines. EU regulations set requirements for testing chemicals for their potential to cause harm, be it through DNA damage, cancer, hormonal disruption or some other way. Often the testing for the harmful effects...
Compliant Stents
Get your stents and implants in compliance with relevant regulations. Stents and other medical implants come into intimate contact with the human body, sometimes over long periods or permanently. As such, they are subject to strict regulations regarding their safety. If you are a manufacturer of stents or implants and want to market them in the...
Nanomaterials in Your Products
Do you use nanomaterials in your production processes, or are they in your final finished product? If so, you are subject to EU regulations that require you to know and document your use of nanomaterials. According to ECHA, products incorporating or consisting of nanomaterials are subject to REACH and CLP regulations. Manufacturers, suppliers,...
Stay Compliant with ECHA Regulations
The substances of very high concern (SVHC) candidate list is constantly changing. In a recent update, eight new substances, widely used in consumer products such as cosmetics, scented articles, rubber, and textiles, were added to the candidate list for restriction in the EU because they are hazardous to human health. All suppliers of physical...
EU no Longer Considers Titanium Dioxide Safe as Food Additive
Titanium dioxide is widely used in the EU as food colourant E171. In May, EFSA announced that titanium dioxide is no longer considered safe when used as a food additive. Recently, a similar concern has been expressed concerning its use as an additive in animal feed. The result of these findings and concerns is that an Acceptable Daily Intake...
Is Your Biological Evaluation Supplier ISO 13485 Certified?
Are you a medical device manufacturer? According to the new Regulation (EC) 2017/745 on medical devices (MDR), medical device manufacturers must demonstrate to notified bodies that all critical suppliers conform with the ISO 13485 standard covering quality management systems. As a critical supplier of high-quality toxicological services, SAXOCON...
Partikler i dit arbejdsmiljø
Er du den arbejdsmiljøansvarlige hos jer? Har I et værksted, en produktion eller et laboratorie? Og ved du, hvad der er i den luft, I indånder? Der findes mange arbejdsprocesser, hvor der kan opstå fine og ultrafine partikler, som kan være farlige for jeres helbred. Hos SAXOCON har vi den nødvendige ekspertise og erfaring til hurtigt at vurdere...
SAXOCON CTO at 2021 Cleaning Validation Conference
SAXOCON is pleased to announce that our CTO, Carsten B. Senholt, will present at the 3rd Cleaning Validation LIVE event on 3 June 2021 at 13:40. Carsten will introduce the basic principles behind establishing Permitted Daily Exposure (PDE) and its role in supporting cleaning validation in shared facilities. Find out more about the conference...
SAXOCON is now ISO 13485:2016 Certified
After more than a year of dedicated effort and nearly 4.000 hours of preparation, we are proud to announce that we have received the globally recognised ISO 13485:2016 certification from BSI under certificate number MD725842. We chose BSI as our certification partner because they are a well-known and respected provider of certification services...
New Partners at SAXOCON
We are so very pleased to announce the addition of three new partners. Our highly skilled and valued colleagues Carsten B. Senholt, Kirsten Kling, and Martin Hover are now partners at SAXOCON. This happy news is also an important step in our development as a business. So, three cheers for our three new partners.
Unexpected Findings
Are you responsible for the production of pharmaceutical products such as vaccines? What if you suddenly find something unexpected? What if there is some foreign material or particles in one of the vials in your production? Sudden unexpected findings of particulate matter in or in contact with drug products are common in pharmaceutical production...
3D Printing and Your Health
Are you using 3D printers to produce mock-ups or in manufacturing? What kind and how many particles are produced while using a 3D printer? Particles produced during 3D printing pose a health risk. In fact, they are almost as harmful as the exhaust produced by Diesel motors. Ensuring good air quality and the health and safety of your workplace...
Food Contact Materials
Packaging is not the first thing we think of when we think of food. However, the materials used in food packaging impact the food contained within. So, it is essential to understand the health and safety consequences presented by the food packaging used. Any materials used for food packaging, known as food contact materials, must be evaluated for...
Get Ready for EU MDR
The deadline, 26 May 2021, for EU MDR is fast approaching. The Danish Medicines Agency (Lægemiddelstyrelsen) recently published guidance regarding the new regulations and their consequences for both industry and Danish authorities. Read their guidance here (Danish only). Keep abreast of the latest news and information regarding MDR and make sure...
Material Readiness
Whether you are manufacturing medical devices, pharmaceuticals or combination products, you will be using materials. Marketing your products in the EU requires that you ensure the quality and safety of the materials used in your products. Early and robust material selection is key to meeting regulatory requirements and mitigating the risk of...
Surface Characterisation
Surfaces are everywhere, and we constantly come into contact with them. To live in this world means touching surfaces, so we rarely give it any thought. But the things that we manufacture that we come into contact with must be safe. This is true for everything we use or wear but especially so for medical devices. Any medical device that comes...
SAXOCON CTO at the Extractables and Leachables Forum 2021
SAXOCON is pleased to announce that our CTO, Carsten B. Senholt, will present at the 2021 Extratables and Leachables forum. Carsten will discuss the importance of materials readiness and its role in the proper selection of robust materials candidates for production. Proper materials selection is key to an intelligent and cost-effective...
Safe Stents and Implants
Stents and other medical implants are products that have a high level of contact with the human body. As such, they are subject to strict regulations regarding their safety. If you are a manufacturer of stents or implants and want to market them in the EU, you will need to apply for a CE Mark certificate. This certificate verifies that the...
Indoor Air Quality Investigations
Air quality problems can often be difficult to pinpoint? You can be doing everything by the book concerning air temperature, humidity, and CO2 levels and still have an air-quality problem. In most cases, when confronted with persistent and difficult-to-diagnose, air-quality mysteries, the culprit is Ultra Fine Particles (UFP). UFPs are defined as...
Secure Worker Health and Safety
Do you know what particles your workers are exposed to in your working environment? Which of these particles is a concern for the health of your workers? Usually, understanding the risks posed by particles associated with processes that generate dust or involve handling powder requires long-term comprehensive studies to assess potential...
Safe Reusable Medical Devices
Reusable medical devices are ubiquitous and necessary tools for medical facilities around the world. As a manufacturer of reusable medical devices who wants to sell them in the EU, you will need to ensure that your cleaning, disinfection, and sterilisation procedures are validated. SAXOCON has the expertise to help you get into compliance with...
Mind the Gap on Nitrosamine Impurities
March 31st is the deadline for the completing your step 1 risk evaluation on potential nitrosamine impurities in medical products. These highly toxic compounds, some of which are considered to be even more carcinogenic than currently established thresholds, are subject to strict regulation in both the EU and US. Let SAXOCON help you to fill in...
Webinar: Pharmaceutical Manufacturing Construction Materials – Part 2
Join us for part 2 of our webinar series on pharmaceutical manufacturing construction materials on Wednesday 3 February 2021 from 14:00 – 15:30 In this seminar, we will discuss how to address particulate matter findings in pharma production facilities. Programme: Welcome and introduction to presenters Is particulate matter a safety concern? - by...
Nanomaterials White Paper
Download our white paper on nanomaterials today! The new EU Medical Devices Regulation (MDR) and IVD Regulation (IVDR) do include specific classification rules for devices that consist of or incorporate nanomaterials. For medical device manufacturers, it is important that they can identify the use of nanomaterials in their devices to ensure that...
Webinar: Pharmaceutical Manufacturing Construction Materials – Part 1
Are your production equipment and systems qualified for product contact? On Wednesday 13 January 2021 from 15:00 – 16:30, we will be hosting a webinar on the role and design of extraction studies to ensure safety and quality in pharmaceutical manufacture. Programme: Welcome and introduction to presenters How to meet regulatory expectations for...
Did You Skip SCIP?
As of today, 5 January 2021, all suppliers of physical products in the EU market are required to track and report the content of substances of very high concern (SVHC). This information shall be made available to consumers and waste operators by filling in the Substance of Concern in Products (SCIP) with the European Chemical Agency (ECHA)....
Safe In Vitro Diagnostics
Do you manufacture an in vitro diagnostic medical device? If so, you will need a CE Mark certificate to market it in the EU. A CE certificate verifies that a product is safe and performs as intended. The regulation, (EU) 2017/746 (IVDR) Annex I, prescribes general safety and performance requirements for the design and verification of an in vitro...
FDA Updating Biocompatability Guidance
The FDA is updating their current thinking regarding the type of biocompatibility information needed for certain devices made from common polymers and fabrics that are in contact with intact skin. Read more about the new FDA Guidance here. SAXOCON can help you pick the right materials that will allow you to waive testing of certain medical device...
EU MDR Day is Upon Us
SAXOCON is ready for the EU MDR, are you? 26 May 2021 is the deadline for the full implementation of the new EU MDR (Medical Device Regulation). This will have far-reaching consequences for all medical device manufacturers that want to sell their products in the European Marketplace. So, to continue marketing your products in the EU after this...
Breathing gas Pathways Regulations
In order to market a medical device in the EU, a CE Mark certificate is needed. This certificate verifies that the product is safe and performs as intended. The ISO 18562-1 standard prescribes a process for testing and documenting the biological safety of the gas pathway of a medical device product intended to provide respiratory care or supply...
Does Your Material Classify as a Nanomaterial?
SAXOCON can test and identify nanomaterials based on EC definitions. Let us help you find out if the materials in your portfolio are, or contain, "nano" and to ensure that they meet all relevant regulatory requirements. Check out our analytical services here.
Ready for the New Requirements for Joint Food Enzyme Dossiers?
EFSA announced changes to the evaluation of food enzymes compiled in a joint dossier in March 2020. If you are part of a joint dossier on food enzymes you may need advice for your toxicological study strategy. SAXOCON’s highly skilled toxicologists can help you in planning, testing, and documenting the safety of your food enzymes. Joint dossiers...
The 1st Extractables and Leachables Network Meeting
SAXOCON A/S is proud to have hosted the first Extractables and Leachables (E&L) network meeting and we are looking forward to participating in this exciting and important network going forward. The E&L network is conceived to support competence building and knowledge sharing among Danish pharmaceutical companies.
We’ve Moved
After a 2019 characterised by rapid growth, SAXOCON has moved to new, bigger offices. Our new headquarters is now located at: Bredevej 2D 2830 Virum
SAXOCON is a Gazelle!
2019 has been quite a year for us here at SAXOCON. In July we became SAXOCON A/S and today we can proudly announce that we are a GAZELLE 2019 recipient. This has only been possible thanks to our loyal customers and our skilled and dedicated SAXOCON employees. We take great pride in delivering high-quality and timely services that make a...
SAXOCON A/S
Today, 1 July 2019, is a great day to be a SAXOCON'er 🙂 We have reached an important milestone and are so proud to announce our new status as SAXOCON A/S.
Alle fagligheder skal i spil, når vi skaber succesfuld innovation
Check out the interview with CEO Martin Friis-Mikkelsen describing the organisational structure at SAXOCON and how it differs from the industry norm. Read the full article here (in Danish)
DTU IP Pitch 2016
SAXOCON was invited to DTU IP Pitch as an example of a "company success story". See SAXOCON CEO Martin Friis-Mikkelsen's presentation here.
SAXOCON i Dynamo – nyhedsmagasin fra DTU
Fra Dynamo 49 | 09 | 16: Spinout-virksomhed fra DTU Fødevareinstituttet: Bedre arbejdsmiljø og medicinsk udstyr Vi efterspørger i stigende grad produkter med avancerede egenskaber. Det giver industrien udfordringer i forbindelse med udvikling af metoder, arbejdsgange og ingredienser, der også tilgodeser behovet for sikkerhed. Det mærker...
Pris til QSAR-teamet på DTU
Pris for at forudsige kemiske stoffers skadelige effekter uden forsøgsdyr Computermodeller udviklet på DTU Fødevareinstituttet kan forudsige en lang række af de skadelige effekter, forskellige kemiske stoffer kan forårsage. Det har ført til øget viden, der kan bruges til at prioritere og vurdere tusinder af kemiske stoffers sikkerhed verden over...
Attend the SAXOCON Seminar on May 31st, 2016
Kravene til medicinsk udstyr er stigende. Har du styr på ISO 10993? Har du styr på, om de materialer, som du anvender i dit produkt er sikre? Følger du den del af guidelinen, som omhandler reduktion af dyreforsøg i forbindelse med den biologiske sikkerhedsvurdering?
Medicoselskaber skal være mere opmærksomme på toksikologi
Check out this article about SAXOCON in MedWatch here.
SAXOCON in DTU News
SAXOCON was born when a good idea and an enterprising investor got together. The researchers behind the idea voluntarily declined to be directly involved in the project. Read more here.
Medico Bazar 2016
Saxocon invites you to join us at the DTU Medico Bazar 2016.
Food-IN-2-Health Agora
SAXOCON will be present at the Food-IN-2-Health Agora conference at Copenhagen University (Marmorhallen), Frederiksberg Campus, 11 November 2015, 9:00–16:00.